"DengiAll", which completed enrolment for phase III trials, is:
- Aa drug to raise the platelet count in dengue
- Ba single-dose vaccine against dengue
- Ca rapid test kit for dengue
- Da mosquito repellent made from neem oil
Show answer and explanation
Correct answer: (b) a single-dose vaccine against dengue
Explanation
DengiAll, by Panacea Biotec with ICMR, is a live attenuated vaccine against DEN-1 to DEN-4.